ORHB — HippoFi Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HippoFi, Inc., formerly ORhub, Inc., is a healthcare innovator. The Company is engaged in delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic and Cancer markets. It is focused on improving patient care and outcomes by utilizing biotech and AI technologies to address degenerative and diseased conditions affecting the quality of life. Its business is designed to drive the Company’s value by commercializing and monetizing advanced solutions, acquiring assets, and licensing technologies, establishing strategic partnerships and industry alliances, and leveraging worldwide sales channels. Its operations comprise two segments: Regenerative Therapeutics and Intelligent Automation. Regenerative Therapeutics division is actively developing and deploying scalable biological solutions into the biotechnology market through its wholly owned subsidiary, PUR Biologics, LLC (PUR). It is also focused on implementing solutions in the Biotech, Fintech, and AI markets.
Directors
- Last Annual
- Last Interim
- Incorporated
- September 8th, 2005
- Public Since
- August 1st, 2006
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 854,229,014
- Address
- 6865 Alton Parkway, Suite 210, IRVINE, 92618
- Web
- https://www.hippofi.info/
- Phone
- +1 4255776266
- Auditors
Similar to ORHB
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advantego
Pink Sheets on Nasdaq
FAQ
As of Today at 21:29 UTC, shares in HippoFi are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in HippoFi last closed at $0.00 and the price had moved by -98.75% over the past 365 days. In terms of relative price strength the HippoFi share price has underperformed the S&P500 Index by -98.98% over the past year.
There is no consensus recommendation for this security.
Find out moreHippoFi does not currently pay a dividend.
HippoFi does not currently pay a dividend.
HippoFi does not currently pay a dividend.
To buy shares in HippoFi you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in HippoFi had a market capitalisation of .
Here are the trading details for HippoFi:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ORHB
Based on an overall assessment of its quality, value and momentum HippoFi is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HippoFi. Over the past six months, its share price has underperformed the S&P500 Index by -98.73%.
As of the last closing price of $0.00, shares in HippoFi were trading -98.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The HippoFi PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on HippoFi's directors